Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
Journal
Cardiovascular and interventional radiology
ISSN: 1432-086X
Titre abrégé: Cardiovasc Intervent Radiol
Pays: United States
ID NLM: 8003538
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
20
11
2020
accepted:
03
03
2021
pubmed:
8
4
2021
medline:
13
7
2021
entrez:
7
4
2021
Statut:
ppublish
Résumé
To compare the relative IPSS (International Prostate Symptom Score) improvement in storage and voiding symptoms between prostatic artery embolization (PAE) and transurethral resection of the prostate (TURP). Retrospective analysis of the UK-ROPE (UK Register of Prostate Embolization) multicentre database was conducted with inclusion of all patients with full IPSS questionnaire score data. The voiding and storage subscore improvement was compared between interventions. Student's t-test (paired and unpaired) and ANOVA (Analysis of variance) were used to identify significant differences between the groups. 146 patients (121 PAE, 25 TURP) were included in the analysis. Storage symptoms were more frequently the most severe symptom ('storage' in 75 patients vs 'voiding' in 17 patients). Between groups, no significant difference was seen in raw storage subscore improvement (TURP 4.9 vs PAE 4.2; p = 0.34) or voiding subscore improvement (TURP 8.4 vs PAE 6.7; p = 0.1). ANOVA demonstrated a greater proportionate reduction (relative to total IPSS) towards voiding symptoms in the TURP group (27.3% TURP vs 9.9% PAE, p = 0.001). Although both TURP and PAE improve voiding symptoms more than storage, a significantly larger proportion of total symptom reduction is due to voiding in the TURP cohort, with PAE providing a more balanced improvement between voiding and storage.
Identifiants
pubmed: 33825062
doi: 10.1007/s00270-021-02821-5
pii: 10.1007/s00270-021-02821-5
pmc: PMC8189939
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1095-1102Références
McWilliams JP, Bilhim TA, Carnevale FC, Bhatia S, Isaacson AJ, Bagla S, et al. Society of interventional radiology multisociety consensus position statement on Prostatic Artery Embolization for treatment of lower urinary tract symptoms attributed to Benign Prostatic Hyperplasia: From the society of interventional radiology, the cardiovascular and interventional radiological society of Europe, SociétéFrançaise de Radiologie, and the British Society of Interventional Radiology [Internet]. J VascIntervRadiol. 2019;30:627–37. https://doi.org/10.1016/j.jvir.2019.02.013 .
doi: 10.1016/j.jvir.2019.02.013
Guidance NICE. Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia: © NICE (2018) Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia. BJU Int. 2018;122(1):11–2.
doi: 10.1111/bju.14404
Maclean D, Harris M, Drake T, Maher B, Modi S, Dyer J, et al. Factors predicting a good symptomatic outcome after prostate artery embolisation (PAE). CardiovascIntervRadiol. 2018;41(8):1152–2115.
du Pisanie J, du Pisanie J, Abumoussa A, Donovan K, Stewart J, Bagla S, et al. Predictors of Prostatic Artery Embolization technical outcomes: patient and procedural factors [Internet]. J VascIntervRadiol. 2019;30:233–40. https://doi.org/10.1016/j.jvir.2018.09.014 .
doi: 10.1016/j.jvir.2018.09.014
Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281(1):289–300.
doi: 10.1148/radiol.2016152292
Little MW, Boardman P, Macdonald AC, Taylor N, Macpherson R, Crew J, et al. Adenomatous-Dominant Benign Prostatic Hyperplasia (AdBPH) as a predictor for clinical success following prostate artery embolization: an age-matched case-control study [Internet]. CardioVascIntervRadiol. 2017;40:682–9. https://doi.org/10.1007/s00270-017-1602-8 .
doi: 10.1007/s00270-017-1602-8
Abt D, Müllhaupt G, Mordasini L, Güsewell S, Markart S, Zumstein V, et al. Outcome prediction of Prostatic Artery Embolization: post hoc analysis of a randomized, open-label, non-inferiority trial [Internet]. BJU Int. 2019;124:134–44. https://doi.org/10.1111/bju.14632 .
doi: 10.1111/bju.14632
pubmed: 30499637
Hacking N, Vigneswaran G, Maclean D, Modi S, Dyer J, Harris M, et al. Technical and Imaging outcomes from the UK registry of prostate artery embolization (uK-ROPE) study: focusing on predictors of clinical success. CardiovascIntervRadiol. 2019;42(5):666–76.
Sun F, Crisóstomo V, Báez-Díaz C, Sánchez FM. Prostatic Artery Embolization (pae) for symptomatic benign prostatic hyperplasia (bph): part 2, insights into the technical rationale. CardiovascIntervRadiol. 2016;39(2):161–9.
Maclean D, Kong M, Lim J, Modi S, Harris M, Bryant T, et al. Does prostate artery embolization (pae) improve voiding symptoms, storage symptoms, or both? CardiovascIntervRadiol. 2020;43(1):23–8.
Moreira AM, de Assis AM, Carnevale FC, Oliveira DS, Antunes AA. Improvements in irritative versus obstructive symptoms of the international prostate symptom score after prostatic artery embolization in 174 patients, in a single center [Internet]. CardioVascular and Interv Radiology. 2020;43:613–9. https://doi.org/10.1007/s00270-019-02398-0 .
doi: 10.1007/s00270-019-02398-0
Lin Y-T, Pereira H, Pellerin O, Déan C, Thiounn N, Sapoval M. Four-Year impact of voiding and storage symptoms in patients with benign prostatic hyperplasia treated with Prostatic Artery Embolization. J VascIntervRadiol. 2020;31(9):1460–6.
Kim TI, Song JM, Chung HC. Analysis of the factors causing bladder irritation after Transurethral resection of the prostate. Korean J Urol. 2010;51(10):700–3.
doi: 10.4111/kju.2010.51.10.700
Kang YJ, Kim KH, Seo Y, Lee KS. Effect of Transurethral resection of the prostate on storage symptoms in patients with benign prostatic hyperplasia of less than 30 ml. World J Mens Health. 2013;31(1):64–9.
doi: 10.5534/wjmh.2013.31.1.64
Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with Transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270–82.
doi: 10.1111/bju.14249